These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28417272)

  • 1. Early administration of neuraminidase inhibitors in adult patients hospitalized for influenza does not benefit survival: a retrospective cohort study.
    Choi SH; Kim T; Park KH; Kwak YG; Chung JW; Lee MS
    Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1673-1677. PubMed ID: 28417272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study.
    Chen L; Han X; Li YL; Zhang C; Xing X
    BMC Infect Dis; 2020 Aug; 20(1):628. PubMed ID: 32842994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical Outcomes.
    Katzen J; Kohn R; Houk JL; Ison MG
    Clin Infect Dis; 2019 Jun; 69(1):52-58. PubMed ID: 30304487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis.
    Venkatesan S; Myles PR; Leonardi-Bee J; Muthuri SG; Al Masri M; Andrews N; Bantar C; Dubnov-Raz G; Gérardin P; Koay ESC; Loh TP; Memish Z; Miller E; Oliva ME; Rath BA; Schweiger B; Tang JW; Tran D; Vidmar T; Waight PA; Nguyen-Van-Tam JS
    Clin Infect Dis; 2017 May; 64(10):1328-1334. PubMed ID: 28199524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of early neuraminidase inhibitor treatment on clinical outcomes in patients with influenza B-related pneumonia: a multicenter cohort study.
    Chen L; Han X; Li Y; Zhang C; Xing X
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1231-1238. PubMed ID: 32026193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.
    Venkatesan S; Myles PR; Bolton KJ; Muthuri SG; Al Khuwaitir T; Anovadiya AP; Azziz-Baumgartner E; Bajjou T; Bassetti M; Beovic B; Bertisch B; Bonmarin I; Booy R; Borja-Aburto VH; Burgmann H; Cao B; Carratala J; Chinbayar T; Cilloniz C; Denholm JT; Dominguez SR; Duarte PAD; Dubnov-Raz G; Fanella S; Gao Z; Gérardin P; Giannella M; Gubbels S; Herberg J; Higuera Iglesias AL; Hoeger PH; Hu XY; Islam QT; Jiménez MF; Keijzers G; Khalili H; Kusznierz G; Kuzman I; Langenegger E; Lankarani KB; Leo YS; Libster RP; Linko R; Madanat F; Maltezos E; Mamun A; Manabe T; Metan G; Mickiene A; Mikić D; Mohn KGI; Oliva ME; Ozkan M; Parekh D; Paul M; Rath BA; Refaey S; Rodríguez AH; Sertogullarindan B; Skręt-Magierło J; Somer A; Talarek E; Tang JW; To K; Tran D; Uyeki TM; Vaudry W; Vidmar T; Zarogoulidis P; ; Nguyen-Van-Tam JS
    J Infect Dis; 2020 Jan; 221(3):356-366. PubMed ID: 31314899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase inhibitors for critically ill children with influenza.
    Louie JK; Yang S; Samuel MC; Uyeki TM; Schechter R
    Pediatrics; 2013 Dec; 132(6):e1539-45. PubMed ID: 24276847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.
    Muthuri SG; Venkatesan S; Myles PR; Leonardi-Bee J; Lim WS; Al Mamun A; Anovadiya AP; Araújo WN; Azziz-Baumgartner E; Báez C; Bantar C; Barhoush MM; Bassetti M; Beovic B; Bingisser R; Bonmarin I; Borja-Aburto VH; Cao B; Carratala J; Cuezzo MR; Denholm JT; Dominguez SR; Duarte PA; Dubnov-Raz G; Echavarria M; Fanella S; Fraser J; Gao Z; Gérardin P; Giannella M; Gubbels S; Herberg J; Higuera Iglesias AL; Hoeger PH; Hoffmann M; Hu X; Islam QT; Jiménez MF; Kandeel A; Keijzers G; Khalili H; Khandaker G; Knight M; Kusznierz G; Kuzman I; Kwan AM; Lahlou Amine I; Langenegger E; Lankarani KB; Leo YS; Linko R; Liu P; Madanat F; Manabe T; Mayo-Montero E; McGeer A; Memish ZA; Metan G; Mikić D; Mohn KG; Moradi A; Nymadawa P; Ozbay B; Ozkan M; Parekh D; Paul M; Poeppl W; Polack FP; Rath BA; Rodríguez AH; Siqueira MM; Skręt-Magierło J; Talarek E; Tang JW; Torres A; Törün SH; Tran D; Uyeki TM; van Zwol A; Vaudry W; Velyvyte D; Vidmar T; Zarogoulidis P; ; Nguyen-Van-Tam JS
    Influenza Other Respir Viruses; 2016 May; 10(3):192-204. PubMed ID: 26602067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of Early Initiation of Neuraminidase Inhibitor Treatment to Hospitalized Patients With Avian Influenza A(H7N9) Virus.
    Zheng S; Tang L; Gao H; Wang Y; Yu F; Cui D; Xie G; Yang X; Zhang W; Ye X; Zhang Z; Wang X; Yu L; Zhang Y; Yang S; Liang W; Chen Y; Li L
    Clin Infect Dis; 2018 Mar; 66(7):1054-1060. PubMed ID: 29077848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09.
    Louie JK; Yang S; Acosta M; Yen C; Samuel MC; Schechter R; Guevara H; Uyeki TM
    Clin Infect Dis; 2012 Nov; 55(9):1198-204. PubMed ID: 22843781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan.
    Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Oba K; Togashi T; Morita K; Inagawa A; Okamura A; Yamazaki S; Shida S; Konno M; Kawamura N; Ishizaka A; Takada K; Tsubakihara K; Nagano N; Shibata M; Furuyama H; Matsuzono Y; Koike A; Murashita M; Hatae Y; Arioka H; Yamanaka T; Watanabe T; Tabata Y; Kumita Y; Hazama K; Akutsu Y; Aoyagi H; Tobise C; Azuma K; Yasoshima K; Sawada Y; Uetsuji K; Tsuchida A; Tsuchiyama A; Yasuda K; Odagawa Y; Yoshioka M
    J Infect Chemother; 2018 Jun; 24(6):449-457. PubMed ID: 29487035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatments.
    Zou Q; Zheng S; Wang X; Liu S; Bao J; Yu F; Wu W; Wang X; Shen B; Zhou T; Zhao Z; Wang Y; Chen R; Wang W; Ma J; Li Y; Wu X; Shen W; Xie F; Vijaykrishna D; Chen Y
    Int J Infect Dis; 2020 Mar; 92():208-213. PubMed ID: 31978583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of corticosteroid and neuraminidase inhibitors on survival in patients with respiratory distress induced by influenza virus.
    Huang SF; Fung CP; Perng DW; Wang FD
    J Microbiol Immunol Infect; 2017 Oct; 50(5):586-594. PubMed ID: 26542650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late diagnosis of influenza in adult patients during a seasonal outbreak.
    Choi SH; Chung JW; Kim T; Park KH; Lee MS; Kwak YG
    Korean J Intern Med; 2018 Mar; 33(2):391-396. PubMed ID: 29117669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients.
    Lee N; Leo YS; Cao B; Chan PK; Kyaw WM; Uyeki TM; Tam WW; Cheung CS; Yung IM; Li H; Gu L; Liu Y; Liu Z; Qu J; Hui DS
    Eur Respir J; 2015 Jun; 45(6):1642-52. PubMed ID: 25573405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicians' attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza.
    Bradbury N; Nguyen-Van-Tam J; Lim WS
    BMC Health Serv Res; 2018 May; 18(1):311. PubMed ID: 29716584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complicated hospitalization due to influenza: results from the Global Hospital Influenza Network for the 2017-2018 season.
    Lina B; Georges A; Burtseva E; Nunes MC; Andrew MK; McNeil SA; Ruiz-Palacios GM; Feng L; Kyncl J; Vanhems P; Ortiz JR; Paget J; Reiner RC;
    BMC Infect Dis; 2020 Jul; 20(1):465. PubMed ID: 32615985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study.
    Hiba V; Chowers M; Levi-Vinograd I; Rubinovitch B; Leibovici L; Paul M
    J Antimicrob Chemother; 2011 May; 66(5):1150-5. PubMed ID: 21393197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential influenza B viral load and susceptibility in children treated with oseltamivir and zanamivir.
    Sato M; Honzumi K; Sato T; Hashimoto K; Watanabe M; Miyazaki K; Kawasaki Y; Hosoya M
    Pediatr Infect Dis J; 2014 Jul; 33(7):e168-72. PubMed ID: 24445826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.